Wednesday, October 28, 2026Daily EditionIndependent journalism
BeCrypto NewsIndependent digital asset reporting
Sign in Write
BTC $79,926 −1.06%ETH $2,305.88 −1.92%SOL $99.59 −1.83%XRP $1.30 −2.62%BNB $746.75 +0.49%DOGE $0.0778 −1.46%Prices: CoinGecko,
Back
Markets

Johnson & Johnson's JNJ-6143 Shows 75% Response Rate in Early Trial

By John Kim for TokenPost

Image: TokenPost

The oral RIPTAC small molecule was previously known as HLD-0915.

Read the full story on TokenPost

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.

Latest in Markets

All Markets stories